Cells treated with 5-FU show an increase in the expression of PD-L1 [3], and cisplatin-resistant lung cancer cells express higher levels of PD-L1 [4], suggesting that upregulation of immunoregulatory mechanisms may be a common feedback mechanism of cancer cells exposed to DNA-damaging drugs or other therapies [32,33]. Here, CD274 is linked to lung carcinoma.